Multicenter Study on Poor Grade Aneurysmal Subarachnoid Hemorrhage Outcomes and Treatments
Led by IRCCS San Raffaele · Updated on 2023-11-29
800
Participants Needed
10
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying patients with poor grade aneurysmal subarachnoid hemorrhage to understand outcomes, predictors, and treatment effects. The study focuses on three key areas early brain injury phase in the emergency department, delayed brain injury phase in the neurocritical care unit, and treatment strategies. Additional research addresses delayed cerebral ischemia and long-term follow-up, as some patients may improve significantly after 6 to 12 months.
This observational study includes patients with poor grade subarachnoid hemorrhage managed according to the latest international and national guidelines. Both prospective and retrospective patients are included, and treatment follows established protocols. The study does not involve experimental treatments but observes standard care practices.
Participants will have their clinical outcomes measured at 6 and 12 months after hemorrhage, with additional long-term follow-up up to 60 months. Researchers will also track delayed cerebral ischemia, rebleeding, treatment complications, and surgical interventions within specified timeframes. Imaging analyses will assess bleeding volumes and ischemic changes. The study aims to provide detailed outcome data and predictors over both short and long terms.
CONDITIONS
Brief Title
Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
Research Team
P
Pietro Panni, P.I., M.D.
A
Andrea Falini, Professor of Neuroradiology
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients admitted to the emergency department because of aneurysmal subarachnoid hemorrhage of poor grade (IV-V) according to the WFNS classification.
You will not qualify if you...
Patients younger than 18 years old.
Pregnant or breast-feeding patients.
Aneurysmal subarachnoid hemorrhage due to trauma or vascular malformations other than cerebral aneurysms.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Monitoring
Duration - Up to 60 months
Participants who undergo routine care are observed according to standard management guidelines for poor grade aneurysmal subarachnoid hemorrhage.
Clinical outcomes assessed at 6 and 12 months, with long-term follow-up up to 60 months
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Study of AI Software for Detecting and Predicting Stability of Unruptured Cerebral Aneurysms Using Non-Invasive Imaging
Studying Enhanced Kidney Clearance in Adults with Serious Brain Illnesses
in Neuroscience Intensive Care Units
Study of Pterygopalatine Fossa Nerve Block Using Ropivacaine and Dexamethasone to Treat Acute Headache After Aneurysmal Subarachnoid Hemorrhage
A Phase II Study of C1 Esterase Inhibitor Cinryze for Treatment of Aneurysmal Subarachnoid Hemorrhage to Reduce Brain Inflammation and Improve Outcomes
Study of Xenon Treatment to Protect the Brain and Improve Recovery After Aneurysmal Subarachnoid Hemorrhage
Study of Factors Linked to the Formation, Growth, and Rupture of Brain Aneurysms in China
A Retrospective Multi-Center Hospital-Based Investigation
Examining Hippocampal Volume and Memory in Patients After Aneurysmal Subarachnoid Hemorrhage During Neurological Rehabilitation
Evaluating Endovascular Infusion of Lidocaine With or Without Steroids for Pain Relief in Patients with Spontaneous Subarachnoid Hemorrhage
Study of Brain and Heart Injury Mechanisms in Adults with Intracranial Hemorrhage Using Multimodal Omics and Imaging
Study of Nimodipine Levels and Effects in Adults with Aneurysmal Subarachnoid Hemorrhage
Observing Treatment Outcomes and Brain Recovery Over 90 Days